Compact proton therapy for fight against cancer

The future face of modern-day anti-cancer therapy based on charged particles like protons could potentially involve using laser accelerators. However, these facilities will need to be reduced in terms of both size and cost compared to conventional ones. A medical physicist is the first to present a new design for the entire complex machine – from the accelerator to the radiation site. In the process, he has successfully cut the facility's size in half.
Source: ScienceDaily Headlines - Category: Science Source Type: news

Related Links:

A new study inCancer Management and Research found a correlation between the age of patients with papillary thyroid cancer and lymph node positivity.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Measures of frailty and comorbidity failed to offer predictive information regarding complications in patients with bladder cancer undergoing radical cystectomy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?, Published online: 17 October 2018; doi:10.1038/s41416-018-0245-0Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults, Published online: 17 October 2018; doi:10.1038/s41416-018-0214-7Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0296-2Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0291-7CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Breast osteoblast-like cells: a new biomarker for the management of breast cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0255-yBreast osteoblast-like cells: a new biomarker for the management of breast cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma, Published online: 17 October 2018; doi:10.1038/s41416-018-0175-xCombination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers, Published online: 17 October 2018; doi:10.1038/s41416-018-0276-6A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”, Published online: 17 October 2018; doi:10.1038/s41416-018-0177-8Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Physics | Proton Therapy | Science